ATE115627T1 - Isolierung und charakterisierung von gegen anthracyclin-antibiotika resistenten gegen. - Google Patents

Isolierung und charakterisierung von gegen anthracyclin-antibiotika resistenten gegen.

Info

Publication number
ATE115627T1
ATE115627T1 AT89906078T AT89906078T ATE115627T1 AT E115627 T1 ATE115627 T1 AT E115627T1 AT 89906078 T AT89906078 T AT 89906078T AT 89906078 T AT89906078 T AT 89906078T AT E115627 T1 ATE115627 T1 AT E115627T1
Authority
AT
Austria
Prior art keywords
characterization
isolation
antibiotic resistant
resistant against
anthracycline antibiotic
Prior art date
Application number
AT89906078T
Other languages
English (en)
Inventor
Marinella Caruso
Anna Luisa Colombo
Luisa Garofano
Francesca Torti
Giuseppe Zanella
Original Assignee
Erba Carlo Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Erba Carlo Spa filed Critical Erba Carlo Spa
Application granted granted Critical
Publication of ATE115627T1 publication Critical patent/ATE115627T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/36Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Actinomyces; from Streptomyces (G)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/65Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression using markers
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/74Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora
    • C12N15/76Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora for Actinomyces; for Streptomyces
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00Preparation of compounds containing saccharide radicals
    • C12P19/44Preparation of O-glycosides, e.g. glucosides
    • C12P19/56Preparation of O-glycosides, e.g. glucosides having an oxygen atom of the saccharide radical directly bound to a condensed ring system having three or more carbocyclic rings, e.g. daunomycin, adriamycin

Landscapes

  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Saccharide Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
AT89906078T 1988-05-27 1989-05-26 Isolierung und charakterisierung von gegen anthracyclin-antibiotika resistenten gegen. ATE115627T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB888812697A GB8812697D0 (en) 1988-05-27 1988-05-27 Isolation & characterisation of genes resistant to anthracycline antibiotics

Publications (1)

Publication Number Publication Date
ATE115627T1 true ATE115627T1 (de) 1994-12-15

Family

ID=10637720

Family Applications (1)

Application Number Title Priority Date Filing Date
AT89906078T ATE115627T1 (de) 1988-05-27 1989-05-26 Isolierung und charakterisierung von gegen anthracyclin-antibiotika resistenten gegen.

Country Status (19)

Country Link
EP (1) EP0371112B1 (de)
JP (1) JP3240052B2 (de)
KR (1) KR970010761B1 (de)
AT (1) ATE115627T1 (de)
AU (1) AU610411B2 (de)
CA (1) CA1335575C (de)
DE (1) DE68920007T2 (de)
DK (1) DK175446B1 (de)
FI (1) FI97728C (de)
GB (1) GB8812697D0 (de)
GR (1) GR1002049B (de)
HU (2) HUT52818A (de)
IE (1) IE66718B1 (de)
IL (1) IL90386A (de)
NZ (1) NZ229237A (de)
PT (1) PT90667B (de)
RU (1) RU2118367C1 (de)
WO (1) WO1989011532A1 (de)
ZA (1) ZA893979B (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AUPN799596A0 (en) * 1996-02-09 1996-03-07 Northern Sydney Area Health Service Chemotherapy resistance gene

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
YU33730B (en) * 1967-04-18 1978-02-28 Farmaceutici Italia Process for preparing a novel antibiotic substance and salts thereof
JPS6158589A (ja) * 1984-08-30 1986-03-25 Meiji Seika Kaisha Ltd ビアラホス生産遺伝子及び耐性遺伝子
US4935340A (en) * 1985-06-07 1990-06-19 Eli Lilly And Company Method of isolating antibiotic biosynthetic genes

Also Published As

Publication number Publication date
RU2118367C1 (ru) 1998-08-27
KR900702024A (ko) 1990-12-05
GR890100339A (el) 1990-03-12
DE68920007T2 (de) 1995-04-27
GR1002049B (en) 1995-11-16
HU217210B (hu) 1999-12-28
HU893264D0 (en) 1990-07-28
AU3692789A (en) 1989-12-12
DK21890D0 (da) 1990-01-26
DK21890A (da) 1990-01-26
DK175446B1 (da) 2004-10-25
FI900359A0 (fi) 1990-01-24
JPH02504470A (ja) 1990-12-20
EP0371112B1 (de) 1994-12-14
KR970010761B1 (ko) 1997-06-30
IE66718B1 (en) 1996-01-24
IL90386A0 (en) 1989-12-15
DE68920007D1 (de) 1995-01-26
IE891730L (en) 1989-11-27
FI97728C (fi) 1997-02-10
EP0371112A1 (de) 1990-06-06
PT90667B (pt) 1994-10-31
WO1989011532A1 (en) 1989-11-30
IL90386A (en) 1995-12-31
ZA893979B (en) 1990-02-28
GB8812697D0 (en) 1988-06-29
HUT52818A (en) 1990-08-28
PT90667A (pt) 1989-11-30
FI97728B (fi) 1996-10-31
AU610411B2 (en) 1991-05-16
CA1335575C (en) 1995-05-16
NZ229237A (en) 1992-05-26
JP3240052B2 (ja) 2001-12-17

Similar Documents

Publication Publication Date Title
FI940909A0 (fi) Lyofilisoituja polyalkyleenioksidimodifioituja proteiini- ja polypeptidikomplekseja, joissa on syklodekstriiniä
AU7264694A (en) Defective adenovirus vectors and use thereof in gene therapy
DE69019412D1 (de) Absorptionsmikroskopie und/oder -spektroskopie mit Abtastmikroskopiesteuerung.
BR9306580A (pt) Xilanase molécula de dna isolda ou recombinada codificando umaxilanase sequência de dna célula hospedeira uso de uma xilanase e molécula de dna isolada ou recombinante
FI943389A0 (fi) Bacillus-lajista saatu ksylanaasi, tällaisen ksylanaasin ja muiden proteiinien ekspressiovektori, niiden isäntäorganismit ja käyttö
IT1226148B (it) Copoliesteri termoplastici segmentati aventi proprieta' elastomeriche.
DE68917393T2 (de) Nichtorientierter siliciumblattstrahl mit ausgezeichneten magnetischen eigenschaften.
NO963487D0 (no) Isolerte, tyrosinaseavledete peptider, samt anvendelser derav
AU8829391A (en) Somatotropins with alterations in the alpha-helix 3 region, alpha-helix 2 region combinations thereof, and in combination with other mutations
IE960874L (en) Macif protein, genes coding therefor, expression vectors¹containing said genes, and transformant cells containing¹said protein
ATE115627T1 (de) Isolierung und charakterisierung von gegen anthracyclin-antibiotika resistenten gegen.
ATE192485T1 (de) 4-0-methyl-transferas codierende dna sequenz
EP0352228A3 (de) Proteine
GB2282601B (en) Antigenically-active proteins/polypeptides and coronavirus vaccines containing the same
DE69406541D1 (de) Farbkontrolle und stabilitätsverbesserungen in acetaminophen
AU6981794A (en) Protein which catalyses peptide refolding and uses thereof
SE8902611D0 (sv) Recombinant dna sequence and its use
IT231244Y1 (it) Perno per maniglie, pomoli e simili
DK52893D0 (da) Polypeptides, dna coding for the polypeptides, and uses thereof
EP0787136A4 (de) Neue mit opazität verbundene proteine, dna welche für diese kodiert und methoden für deren verwendung
IT8747894A0 (it) Mobiletto scalda-aria munito di valvole di aspirazione e miscelazione

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
EEIH Change in the person of patent owner
REN Ceased due to non-payment of the annual fee